8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSIONWashington, D.C.  20549FORM 8-KCURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: July 27, 2010(Date of earliest event reported):INNODATA ISOGEN, INC.(Exact name of registrant as specified in its charter)

Delaware	0-22196	13-3475943
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Three University Plaza Hackensack, NJ 07601	07601
(Address of principal executive offices)	(Zip Code)

(201) 371-8000(Registrant’s telephone number, including area code)N/A(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02   Results of Operations and Financial Condition.

       On July 27, 2010, Innodata Isogen, Inc. issued a press release announcing its second quarter 2010 financial results.  A copy of the press release is attached hereto as Exhibit 99.1.

       In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01   Financial Statements and Exhibits.

99.1                Press release dated July 27, 2010.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		INNODATA ISOGEN, INC.
Date:	July 27, 2010	By:	/s/ O’Neil Nalavadi
			O’Neil Nalavadi
			Senior Vice President and Chief Financial Officer

3

INDEX TO EXHIBITS

Exhibit No.	Description
99.1	Press Release of Innodata Isogen, Inc., dated July 27, 2010, reporting second quarter 2010 financial results.

4

EX-99.1

Exhibit 99.1

Innodata Isogen Reports Second Quarter 2010 Results

Authorizes $2.1 Million Stock Repurchase Program

NEW YORK--(BUSINESS WIRE)--July 27, 2010--INNODATA ISOGEN, INC. (NASDAQ: INOD), today reported results for the second quarter ended June 30, 2010 and the first six months of 2010.

• Total revenue was $15.4 million for the second quarter of 2010, compared to $15.5 million in the first quarter of 2010, and $20.9 million in the second quarter of 2009.
• The $5.5 million decline from the second quarter of 2009 was primarily due to reduced business volume from one of Innodata Isogen’s two largest clients, partially offset by continued growth in other areas of the company’s business.
• Pre-tax loss was approximately $0.5 million in the second quarter of 2010 compared to a pre-tax loss of $0.9 million in the first quarter of 2010, and pre-tax income of $4.4 million in the second quarter of 2009.
• Net loss for the second quarter of 2010 was $0.9 million or ($0.03) per diluted share, compared to a net loss of $1.4 million or ($0.06) per diluted share in the first quarter of 2010, and net income of $3.2 million, or $0.13 per diluted share in the second quarter of 2009.
• In the first six months of 2010, revenue was $30.9 million, down 27% from revenue of $42.0 million in the first six months of 2009. Net loss in the first half of 2010 was $2.3 million, or ($0.09) per diluted share, compared to net income of $6.8 million, or $0.27 per diluted share, in the first half of 2009.
• The company’s balance sheet continues to be strong with $27.0 million of cash and cash equivalents and investments as of June 30, 2010, compared to $25.8 million as of March 31, 2010.

Innodata Isogen also announced that its board of directors has authorized the repurchase of up to $2.1 million of its common stock in open market or private transactions. The timing and nature of repurchases are subject to market and business conditions and applicable securities laws. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice. The repurchase authorization replaces a $2.0 million authorization made in May 2008 under which the company bought approximately 606,000 shares for approximately $1.9 million.

“At every level, our organization has been focused on recovering from the operating issues that impacted us earlier in 2010,” said Jack Abuhoff, Chairman and CEO of Innodata Isogen. “We continue to see that publishers and other enterprise customers have a real need for the kinds of editorial and production services that Innodata Isogen is known for, and I remain confident that we are taking the necessary steps to resume growth and address our market opportunity over time.

“Our board’s decision to authorize the share repurchase program underscores their confidence in our market opportunity and long-term strategy. At the same time, we continue to benefit from a strong balance sheet that will support continued investment in our business.”

Timing of Conference Call with Q&A

Innodata Isogen will conduct an earnings conference call, including a question & answer period, at 11AM ET today. You can participate in this call by dialing the following call-in numbers:

The call-in numbers for the conference call are:

1-888-245-0987 (Domestic)

1-913-981-5582 (International)

1-888-203-1112 (Domestic Replay)

1-719-457-0820 (International Replay)

Pass code on replay only: 9974628

Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of www.innodata-isogen.com. Please note that the Webcast feature will be in listen-only mode.

Call-in or Webcast replay will be available for 30 days following the conference call.

About Innodata Isogen

Innodata Isogen (NASDAQ: INOD), is a leading provider of knowledge process outsourcing (KPO) services, as well as publishing and related information technology (IT) services.

We work as a product development partner to our clients, helping them meet their content creation and publishing challenges. We provide outsourcing services that draw upon onshore and offshore resources, proven project management and highly engineered processes and tools. We also help our clients improve their internal business operations with process and systems engineering. Our clients include leading enterprises in information-intensive industries such as media, publishing and information services, high technology, manufacturing, aerospace, defense, law, government and intelligence.

Recent honors include EContent Magazine’s EContent 100, KMWorld Magazine’s 100 Companies That Matter in Knowledge Management, the International Association of Outsourcing Professionals’ (IAOP) Global Outsourcing Top 100, D&B India’s Leading ITeS and BPO Companies and the Black Book of Outsourcing’s Top List of Leading Outsourcing Providers to the Printing and Publishing Business.

Headquartered in the New York metro area, Innodata Isogen has offices and operations in the United States, the United Kingdom, France, Israel, China, India, Sri Lanka, and the Philippines.

This release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “project,” “head start,” "believe," "expect," “should,” "anticipate," "indicate," "point to," “forecast,” “likely” and other similar expressions generally identify forward-looking statements, which speak only as of their dates.

These forward-looking statements are based largely on our current expectations, and are subject to a number of risks and uncertainties, including without limitation, the primarily at-will nature of the company's contracts with its customers and the ability of customers to reduce, delay or cancel projects, including projects that the company regards as recurring; continuing revenue concentration in a limited number of clients; continuing reliance on project-based work; inability to replace projects that are completed, cancelled or reduced; depressed market conditions; changes in external market factors; the ability and willingness of our customers and prospective customers to execute business plans which give rise to requirements for digital content and professional services in knowledge processing; difficulty in integrating and deriving synergies from acquisitions; potential undiscovered liabilities of companies that we acquire; changes in our business or growth strategy; the emergence of new or growing competitors; various other competitive and technological factors; and other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission.

Actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements contained in this release will occur.

INNODATA ISOGEN, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)
	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2010			2009			2010			2009
Revenues	$	15,386		$	20,905		$	30,860		$	42,017
Operating costs and expenses:
Direct operating expenses		12,107			13,469			24,379			25,876
Selling and administrative expenses		3,770			3,063			7,905			6,670
Interest income, net		(33	)		(6	)		(35	)		(19	)
Total		15,844			16,526			32,249			32,527
Income (loss) before provision for income taxes		(458	)		4,379			(1,389	)		9,490
Provision for income taxes		416			1,175			889			2,705
Net income (loss)	$	(874	)	$	3,204		$	(2,278	)	$	6,785
Income (loss) per share:
Basic	$	(.03	)	$	.13		$	(.09	)	$	.28
Diluted	$	(.03	)	$	.13		$	(.09	)	$	.27
Weighted average shares outstanding:
Basic		25,419			24,249			25,400			24,194
Diluted		25,419			25,373			25,400			24,912

INNODATA ISOGEN, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in thousands)
	June 30,		December 31,
	2010		2009
ASSETS
Current assets:
Cash and cash equivalents	$	19,448	$	26,480
Short term investments - other		5,577		-
Accounts receivable, net		10,140		11,741
Prepaid expenses and other current assets		2,554		3,899
Deferred income taxes		1,677		1,763
Total current assets		39,376		43,883
Property and equipment, net		5,130		5,559
Other assets		2,303		2,505
Long term investment - other		2,000		-
Deferred income taxes		909		943
Goodwill		675		675
Total assets	$	50,393	$	53,565
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	3,173	$	3,554
Accrued salaries, wages and related benefits		5,274		5,022
Income and other taxes		1,354		1,339
Current portion of long-term obligations		572		892
Deferred income taxes		42		487
Total current liabilities		10,415		11,294
Deferred income taxes		87		87
Income and other taxes – long term		360		-
Long term obligations		1,325		1,199
Stockholders' equity		38,206		40,985
Total liabilities and stockholders’ equity	$	50,393	$	53,565

CONTACT:
Innodata Isogen, Inc.
Corey D. Luskin, 201-371-8055
Vice President
cluskin@innodata-isogen.com